“MetaTech (AP) Inc.” was founded in 1998. Our management philosophy is “integrity, teamwork, challenge, and optimism” to create excellent business performance. In addition, we became officially listed at the over-the-counter market in Taiwan in June 2004. Currently, our paid-in capital is NT$682 million, and the scope of our business includes two main business groups, electronics business group and biomedicine business group.
Over the past two decades, MetaTech focused on the business of electronic component agency. The product application includes industrial PC, server/ storage, network communication, power supply, and wireless communication products. Our headquarters is in New Taipei City, Taiwan. We also have subsidiaries in Hong Kong, Shenzhen, Singapore as well as branches or offices in Beijing, Shanghai, Chengdu, Suzhou, Kuala Lumpur, Penang, Thailand, the Philippines, Vietnam, and India. Our products are marketed all over Taiwan, China, and Southeast Asia.
In 2017, MetaTech transferred the technology of cell sheet culturing from Japan, and formally entered the area of regenerative medicine business. At present, MetaTech product “knee cartilage cell sheet” has been not only treating the highest number of patients in the world but also has 100% successful treatment. We also have signed a contract with National Health Research Institutes, and are looking forward to applying for the New Drugs Application based on the real world data and evidence.
MetaTech self-developed technique “micro 3D structure cell sheet with high proliferative activity” (in short, M-Cell), which obtained two patents in Taiwan, and reward the 16th National Innovation Award “high-efficiency aggregated fibroblast”. This product was approved by Regulations of Special Medical Techniques to be used in three hospitals and four clinics to cure skin problems, including filling and repairing of wrinkles, pockmarks, and scars. We will aggressively expand the market of aesthetic medicine.
Over the past two decades, MetaTech focused on the business of electronic component agency. The product application includes industrial PC, server/ storage, network communication, power supply, and wireless communication products. Our headquarters is in New Taipei City, Taiwan. We also have subsidiaries in Hong Kong, Shenzhen, Singapore as well as branches or offices in Beijing, Shanghai, Chengdu, Suzhou, Kuala Lumpur, Penang, Thailand, the Philippines, Vietnam, and India. Our products are marketed all over Taiwan, China, and Southeast Asia.
In 2017, MetaTech transferred the technology of cell sheet culturing from Japan, and formally entered the area of regenerative medicine business. At present, MetaTech product “knee cartilage cell sheet” has been not only treating the highest number of patients in the world but also has 100% successful treatment. We also have signed a contract with National Health Research Institutes, and are looking forward to applying for the New Drugs Application based on the real world data and evidence.
MetaTech self-developed technique “micro 3D structure cell sheet with high proliferative activity” (in short, M-Cell), which obtained two patents in Taiwan, and reward the 16th National Innovation Award “high-efficiency aggregated fibroblast”. This product was approved by Regulations of Special Medical Techniques to be used in three hospitals and four clinics to cure skin problems, including filling and repairing of wrinkles, pockmarks, and scars. We will aggressively expand the market of aesthetic medicine.